Cha DR - Search Results

1

Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells.

Kim NH, Jung HH, Cha DR, Choi DS. Kim NH, et al. Among authors: cha dr. J Endocrinol. 2000 Jun;165(3):617-24. doi: 10.1677/joe.0.1650617. J Endocrinol. 2000. PMID: 10828845

2

A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells.

Ihm CG, Park JK, Hong SP, Lee TW, Cho BS, Kim MJ, Cha DR, Ha H. Ihm CG, et al. Among authors: cha dr. Nephron. 1998;79(1):33-7. doi: 10.1159/000044988. Nephron. 1998. PMID: 9609459

3

Role of vascular endothelial growth factor in diabetic nephropathy.

Cha DR, Kim NH, Yoon JW, Jo SK, Cho WY, Kim HK, Won NH. Cha DR, et al. Kidney Int Suppl. 2000 Sep;77:S104-12. doi: 10.1046/j.1523-1755.2000.07717.x. Kidney Int Suppl. 2000. PMID: 10997699

4

Effects of high glucose on interleukin-6 production in human mesangial cells.

Ihm CG, Park JK, Kim HJ, Lee TW, Cha DR. Ihm CG, et al. Among authors: cha dr. J Korean Med Sci. 2002 Apr;17(2):208-12. doi: 10.3346/jkms.2002.17.2.208. J Korean Med Sci. 2002. PMID: 11961304 Free PMC article.

5

Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.

Kim NH, Kim KB, Kim DL, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR. Kim NH, et al. Among authors: cha dr. Diabet Med. 2004 Jun;21(6):545-51. doi: 10.1111/j.1464-5491.2004.01200.x. Diabet Med. 2004. PMID: 15154937

6

Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.

Cha DR, Kang YS, Han SY, Jee YH, Han KH, Han JY, Kim YS, Kim NH. Cha DR, et al. J Endocrinol. 2004 Oct;183(1):183-94. doi: 10.1677/joe.1.05647. J Endocrinol. 2004. PMID: 15525586

7

Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.

Cha DR, Kim IS, Kang YS, Han SY, Han KH, Shin C, Ji YH, Kim NH. Cha DR, et al. Diabet Med. 2005 Jan;22(1):14-20. doi: 10.1111/j.1464-5491.2004.01295.x. Diabet Med. 2005. PMID: 15606685

8

Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy.

Kim NH, Oh JH, Seo JA, Lee KW, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR. Kim NH, et al. Among authors: cha dr. Kidney Int. 2005 Jan;67(1):167-77. doi: 10.1111/j.1523-1755.2005.00067.x. Kidney Int. 2005. PMID: 15610240 Free article.

9

Effect of IgA aggregates on transforming growth factor-beta1 production in human mesangial cells and the intraglomerular expression of transforming growth factor-beta1 in patients with IgA nephropathy.

Han SY, Ihm CG, Cha DR, Kang YS, Han KH, Kim HK, Han JY. Han SY, et al. Among authors: cha dr. Korean J Intern Med. 2005 Mar;20(1):40-7. doi: 10.3904/kjim.2005.20.1.40. Korean J Intern Med. 2005. PMID: 15906952 Free PMC article.

10

High glucose and angiotensin II increase beta1 integrin and integrin-linked kinase synthesis in cultured mouse podocytes.

Han SY, Kang YS, Jee YH, Han KH, Cha DR, Kang SW, Han DS. Han SY, et al. Among authors: cha dr. Cell Tissue Res. 2006 Feb;323(2):321-32. doi: 10.1007/s00441-005-0065-4. Epub 2005 Sep 28. Cell Tissue Res. 2006. PMID: 16189717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters